Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tetraspanin CD9 alters cellular trafficking and endocytosis of tetraspanin CD63, affecting CD63 packaging into small extracellular vesicles.

The Journal of biological chemistry·2025

Same author

ADAR1 Regulates Lipid Remodeling to Dictate Ferroptosis Sensitivity.

bioRxiv : the preprint server for biology·2025

Same author

The Epstein-Barr Virus Nuclear Antigen 1 Variant Associated with Nasopharyngeal Carcinoma Defines the Sequence Criteria for Serologic Risk Prediction.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024

Same author

Editorial: Double-edged swords: important factors connecting metabolic disorders and cancer development - from basic research to translational applications, volume II.

Frontiers in endocrinology·2024

Same author

Elliott Dan Kieff, MD, PhD (1943-2024).

Cell·2024

Same author

Machine learning-based analysis of cancer cell-derived vesicular proteins revealed significant tumor-specificity and predictive potential of extracellular vesicles for cell invasion and proliferation - A meta-analysis.

Cell communication and signaling : CCS·2023

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Human tumor virus utilizes exosomes for intercellular communication.

David G Meckes¹, Kathy H Y Shair, Aron R Marquitz

¹The Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA.

Proceedings of the National Academy of Sciences of the United States of America

|November 10, 2010

Summary

This summary is machine-generated.

Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in nasopharyngeal carcinoma (NPC) exosomes promotes tumor growth. These exosomes transfer LMP1, signaling molecules, and viral microRNAs to recipient cells, influencing the tumor microenvironment.

More Related Videos

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Published on: August 26, 2021

Related Experiment Videos

Last Updated: Jun 6, 2026

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Direct Stochastic Optical Reconstruction Microscopy of Extracellular Vesicles in Three Dimensions

Published on: August 26, 2021

Area of Science:

Oncology
Virology
Cell Biology

Background:

Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) is implicated in human malignancies and immune modulation.
Exosomes are extracellular vesicles involved in intercellular communication, promoting tumor progression.
Nasopharyngeal carcinoma (NPC) is an EBV-associated malignancy where exosome function is under investigation.

Purpose of the Study:

To investigate the contents and functional effects of exosomes derived from EBV-infected NPC cells.
To determine the role of LMP1 and viral microRNAs within these exosomes.
To understand how NPC-derived exosomes influence recipient cell signaling and the tumor microenvironment.

Main Methods:

Characterization of exosome cargo from EBV-positive NPC cells, including proteins and microRNAs.
Analysis of signaling pathway activation (ERK, AKT) in recipient cells upon exposure to NPC exosomes.
Assessment of epidermal growth factor receptor (EGFR) expression in response to LMP1 and exosome treatment.

Main Results:

Exosomes from EBV-infected NPC cells contain LMP1, signal transduction molecules, and viral microRNAs.
Exposure to these exosomes activates ERK and AKT signaling pathways in recipient cells.
NPC exosomes are enriched in viral microRNAs and can transfer LMP1 and EGFR, modulating cellular properties.

Conclusions:

EBV-encoded LMP1 and viral microRNAs within exosomes contribute to tumor progression.
NPC-derived exosomes act as mediators, transferring bioactive molecules to manipulate the tumor microenvironment.
Exosome content and properties are modulated by EBV and LMP1, impacting intercellular communication in cancer.